Nifekalant
From Self-sufficiency
| File:Nifekalant.png | |
| Systematic (IUPAC) name | |
|---|---|
|
6-[(2-{(2-hydroxyethyl)[3-(4-nitrophenyl)propyl]amino}ethyl)amino]-1,3-dimethylpyrimidine-2,4(1H,3H)-dione | |
| Clinical data | |
| Routes of administration | IV |
| Legal status | |
| Legal status |
|
| Identifiers | |
| CAS Number | 130636-43-0 |
| ATC code | none |
| PubChem | CID 4486 |
| Chemical data | |
| Formula | C19H27N5O5 |
| Molar mass | 405.44 g/mol[[Script error: No such module "String".]] |
| Script error: No such module "collapsible list". | |
Nifekalant (INN) is a class III antiarrhythmic agent approved in Japan for the treatment of arrhythmias and ventricular tachycardia.[1] It has the brand name Shinbit.
References
Cite error: Invalid <references> tag;
parameter "group" is allowed only.
<references />, or <references group="..." />
| 30px | This drug article relating to the cardiovascular system is a stub. You can help ssf by expanding it. |
- ↑ Lua error in package.lua at line 80: module 'Module:Citation/CS1/Suggestions' not found.
Categories:
- Pages with script errors
- Pages with broken file links
- Drugs with non-standard legal status
- Infobox drug tracked parameters
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs not assigned an ATC code
- Articles containing unverified chemical infoboxes
- 2Fix
- Antiarrhythmic agents
- Pyrimidines
- Nitro compounds
- Potassium channel blockers
- Cardiovascular system drug stubs
